UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 570

Sortiert nach

Blockade of the Phagocytic Receptor MerTK on Tumor-Associated Macrophages Enhances P2X7R-Dependent STING Activation by Tumor-Derived cGAMP

Immunity (Cambridge, Mass.), 2020-02, Vol.52 (2), p.357-373.e9

2020

Volltextzugriff (PDF)

Blocking immunoinhibitory receptor LILRB2 reprograms tumor-associated myeloid cells and promotes antitumor immunity

The Journal of clinical investigation, 2018-12, Vol.128 (12), p.5647-5662

2018

Volltextzugriff (PDF)

Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1

Journal for immunotherapy of cancer, 2018-12, Vol.6 (1), p.151-151, Article 151

2018

Volltextzugriff (PDF)

A simple and effective method to purify and activate T cells for successful generation of chimeric antigen receptor T (CAR-T) cells from patients with high monocyte count

Journal of translational medicine, 2022-12, Vol.20 (1), p.608-608, Article 608

2022

Volltextzugriff (PDF)

Efficient Cross-presentation Depends on Autophagy in Tumor Cells

Cancer research (Chicago, Ill.), 2008-09, Vol.68 (17), p.6889-6895

2008

Volltextzugriff (PDF)

SPIO Enhance the Cross-Presentation and Migration of DCs and Anionic SPIO Influence the Nanoadjuvant Effects Related to Interleukin-1β

Nanoscale research letters, 2018-12, Vol.13 (1), p.409-11, Article 409

2018

Volltextzugriff (PDF)

Tumor-Derived Autophagosome Vaccine: Mechanism of Cross-Presentation and Therapeutic Efficacy

Clinical cancer research, 2011-11, Vol.17 (22), p.7047-7057

2011

Volltextzugriff (PDF)

Polyethyleneimine modification of aluminum hydroxide nanoparticle enhances antigen transportation and cross-presentation of dendritic cells

International journal of nanomedicine, 2018-01, Vol.13, p.3353-3365

2018

Volltextzugriff (PDF)

Tumor-Derived Autophagosome Vaccine: Induction of Cross-Protective Immune Responses against Short-lived Proteins through a p62-Dependent Mechanism

Clinical cancer research, 2011-10, Vol.17 (20), p.6467-6481

2011

Volltextzugriff (PDF)

Alpha-alumina nanoparticles induce efficient autophagy-dependent cross-presentation and potent antitumour response

Nature nanotechnology, 2011-09, Vol.6 (10), p.645-650

2011

Volltextzugriff (PDF)

Tumor-released autophagosomes induces CD4 + T cell-mediated immunosuppression via a TLR2-IL-6 cascade

Journal for immunotherapy of cancer, 2019-07, Vol.7 (1), p.178-178, Article 178

2019

Volltextzugriff (PDF)

OX40 agonist stimulation increases and sustains humoral and cell-mediated responses to SARS-CoV-2 protein and saRNA vaccines

Frontiers in immunology, 2022-09, Vol.13, p.896310-896310

2022

Volltextzugriff (PDF)

Peritumoral administration of DRibbles-pulsed antigen-presenting cells enhances the antitumor efficacy of anti-GITR and anti-PD-1 antibodies via an antigen presenting independent mechanism

Journal for immunotherapy of cancer, 2019-11, Vol.7 (1), p.311-311, Article 311

2019

Volltextzugriff (PDF)

Tumor-derived autophagosomes (DRibbles) induce B cell activation in a TLR2-MyD88 dependent manner

PloS one, 2013-01, Vol.8 (1), p.e53564-e53564

2013

Volltextzugriff (PDF)

Glimpse into the future: harnessing autophagy to promote anti-tumor immunity with the DRibbles vaccine

Journal for immunotherapy of cancer, 2016-05, Vol.4 (1), p.25-25, Article 25

2016

Volltextzugriff (PDF)

Immunocompetence and mechanism of the DRibble-DCs vaccine for oral squamous cell carcinoma

Cancer management and research, 2018-01, Vol.10, p.493-501

2018

Volltextzugriff (PDF)

763 Initial results from phase I dose escalation trial of CAN1012 in patients with solid tumor malignancies

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A858-A858

2023

Volltextzugriff (PDF)

148 Characterizing cancer’s dark matter, short-lived proteins, and defective ribosomal products, presented by cancer and contained in the DPV-001 cancer vaccine

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A168-A168

2023

Volltextzugriff (PDF)

Autophagosome-based strategy to monitor apparent tumor-specific CD8 T cells in patients with prostate cancer

Oncoimmunology, 2018-12, Vol.7 (12), p.e1466766-e1466766

2018

Volltextzugriff (PDF)

Cross-presentation of tumor associated antigens through tumor-derived autophagosomes

Autophagy, 2009-05, Vol.5 (4), p.576-577

2009

Volltextzugriff (PDF)

Activating the Nucleic Acid-Sensing Machinery for Anticancer Immunity

International review of cell and molecular biology, 2019-01, Vol.344, p.173-214

2019

Volltextzugriff (PDF)

A pilot study of an autologous tumor-derived autophagosome vaccine with docetaxel in patients with stage IV non-small cell lung cancer

Journal for immunotherapy of cancer, 2017-12, Vol.5 (1), p.103-103, Article 103

2017

Volltextzugriff (PDF)

CD122⁺CD8⁺ Treg suppress vaccine-induced antitumor immune responses in lymphodepleted mice

European journal of immunology, 2010-05, Vol.40 (5), p.1375-1385

2010

Volltextzugriff (PDF)

443 An immunotherapy trio in advanced HNSCC for coordinated B and T cell antigen response

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A469-A469

2020

Volltextzugriff (PDF)

Expansion of KRAS hotspot mutations reactive T cells from human pancreatic tumors using autologous T cells as the antigen-presenting cells

Cancer Immunology, Immunotherapy, 2023-05, Vol.72 (5), p.1301-1313

2023

Volltextzugriff (PDF)

1 – 25 von 570

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(484)
Mit Volltextzugriff
(521)

Publikationsform

Sprache

Englisch
(520)
Chinesisch
(55)
Japanisch
(50)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Blockade of the Phagocytic Receptor MerTK on Tumor-Associated Macrophages Enhances P2X7R-Dependent STING Activation by Tumor-Derived cGAMP

Blocking immunoinhibitory receptor LILRB2 reprograms tumor-associated myeloid cells and promotes antitumor immunity

Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1

A simple and effective method to purify and activate T cells for successful generation of chimeric antigen receptor T (CAR-T) cells from patients with high monocyte count

Efficient Cross-presentation Depends on Autophagy in Tumor Cells

SPIO Enhance the Cross-Presentation and Migration of DCs and Anionic SPIO Influence the Nanoadjuvant Effects Related to Interleukin-1β

Tumor-Derived Autophagosome Vaccine: Mechanism of Cross-Presentation and Therapeutic Efficacy

Polyethyleneimine modification of aluminum hydroxide nanoparticle enhances antigen transportation and cross-presentation of dendritic cells

Tumor-Derived Autophagosome Vaccine: Induction of Cross-Protective Immune Responses against Short-lived Proteins through a p62-Dependent Mechanism

Alpha-alumina nanoparticles induce efficient autophagy-dependent cross-presentation and potent antitumour response

Tumor-released autophagosomes induces CD4 + T cell-mediated immunosuppression via a TLR2-IL-6 cascade

OX40 agonist stimulation increases and sustains humoral and cell-mediated responses to SARS-CoV-2 protein and saRNA vaccines

Peritumoral administration of DRibbles-pulsed antigen-presenting cells enhances the antitumor efficacy of anti-GITR and anti-PD-1 antibodies via an antigen presenting independent mechanism

Tumor-derived autophagosomes (DRibbles) induce B cell activation in a TLR2-MyD88 dependent manner

Glimpse into the future: harnessing autophagy to promote anti-tumor immunity with the DRibbles vaccine

Immunocompetence and mechanism of the DRibble-DCs vaccine for oral squamous cell carcinoma

763 Initial results from phase I dose escalation trial of CAN1012 in patients with solid tumor malignancies

148 Characterizing cancer’s dark matter, short-lived proteins, and defective ribosomal products, presented by cancer and contained in the DPV-001 cancer vaccine

Autophagosome-based strategy to monitor apparent tumor-specific CD8 T cells in patients with prostate cancer

Cross-presentation of tumor associated antigens through tumor-derived autophagosomes

Activating the Nucleic Acid-Sensing Machinery for Anticancer Immunity

A pilot study of an autologous tumor-derived autophagosome vaccine with docetaxel in patients with stage IV non-small cell lung cancer

CD122⁺CD8⁺ Treg suppress vaccine-induced antitumor immune responses in lymphodepleted mice

443 An immunotherapy trio in advanced HNSCC for coordinated B and T cell antigen response

Expansion of KRAS hotspot mutations reactive T cells from human pancreatic tumors using autologous T cells as the antigen-presenting cells

Suchergebnisse filtern